Efficacy and Safety of Deep Brain Stimulation in Patients With Medication-Induced Tardive Dyskinesia and/or Dystonia

2012 ◽  
Vol 73 (11) ◽  
pp. 1434-1438 ◽  
Author(s):  
Charlotte L. Mentzel ◽  
Diederik E. Tenback ◽  
Marina A. J. Tijssen ◽  
Veerle E. R. M. Visser-Vandewalle ◽  
Peter N. van Harten
2018 ◽  
Vol 75 (3) ◽  
pp. 353 ◽  
Author(s):  
Daniel Martinez-Ramirez ◽  
Joohi Jimenez-Shahed ◽  
James Frederick Leckman ◽  
Mauro Porta ◽  
Domenico Servello ◽  
...  

2014 ◽  
Vol 44 (3) ◽  
pp. 123-125 ◽  
Author(s):  
Muhammad Puri ◽  
Ahmed Albassam ◽  
Bennett Silver

2020 ◽  
pp. 233-238
Author(s):  
Shannon Y. Chiu ◽  
Irene A. Malaty

Tardive disorders encompass phenomenologically diverse delayed-onset persistent involuntary motor symptoms associated with exposure to dopamine receptor blocking agents. Two common tardive disorders encountered in the clinical setting include tardive dyskinesia and tardive dystonia. This chapter presents a patient with severe refractory tardive dyskinesia and also tardive dystonia, manifesting as frequent and disabling retropulsion. He initially underwent bilateral globus pallidus interna (GPi) deep brain stimulation (DBS) but was found to have lead migration secondary to his severe hyperkinetic movements. He had persistent symptoms despite lead revision and ultimately required bilateral subthalamic nucleus (STN) rescue DBS implantation. The rescue procedure was synergistic with the initial GPi DBS and markedly improved his symptoms. Severe tardive dyskinesia and dystonia may respond to bilateral GPi DBS, and if necessary, rescue STN DBS can be added.


2017 ◽  
Vol 381 ◽  
pp. 233
Author(s):  
Y. Hayashi ◽  
M.A. Higuchi ◽  
T. Morishita ◽  
T. Mishima ◽  
T. Inoue ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document